Publicaciones en colaboración con investigadores/as de Universidad de Salamanca (21)

2023

  1. A Potential Effect of Circadian Rhythm in the Delivery/Therapeutic Performance of Paclitaxel–Dendrimer Nanosystems

    Journal of Functional Biomaterials, Vol. 14, Núm. 7

  2. METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer

    Molecular cancer, Vol. 22, Núm. 1, pp. 119

  3. Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis

    Blood, Vol. 141, Núm. 4, pp. 406-421

2022

  1. A novel nonsense variant in TPM4 caused dominant macrothrombocytopenia, mild bleeding tendency and disrupted cytoskeleton remodeling

    Journal of Thrombosis and Haemostasis, Vol. 20, Núm. 5, pp. 1248-1255

  2. CRISPR/Cas9‐Directed Gene Trap Constitutes a Selection System for Corrected BCR/ABL Leukemic Cells in CML

    International Journal of Molecular Sciences, Vol. 23, Núm. 12

2021

  1. Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression

    Blood Cancer Journal, Vol. 11, Núm. 7

  2. CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia

    CRISPR Journal, Vol. 4, Núm. 4, pp. 519-535

  3. Characterization of the platelet phenotype caused by a germline RUNX1 Variant in a CRISPR/Cas9-generated murine model

    Thrombosis and Haemostasis, Vol. 121, Núm. 9, pp. 1193-1205

  4. Cyba-deficient mice display an increase in hematopoietic stem cells and an overproduction of immunoglobulins

    Haematologica, Vol. 106, Núm. 1, pp. 142-153

  5. Future approaches for treating chronic myeloid leukemia: Crispr therapy

    Biology, Vol. 10, Núm. 2, pp. 1-16

  6. Granuloma formation in a cyba-deficient model of chronic granulomatous disease is associated with myeloid hyperplasia and the exhaustion of B-cell lineage

    International Journal of Molecular Sciences, Vol. 22, Núm. 16

2020

  1. CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition

    Leukemia, Vol. 34, Núm. 6, pp. 1599-1612

  2. ETV6/RUNX1 Fusion Gene Abrogation Decreases the Oncogenicity of Tumour Cells in a Preclinical Model of Acute Lymphoblastic Leukaemia

    Cells, Vol. 9, Núm. 1

  3. Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology

    Molecular Biology Reports, Vol. 47, Núm. 2, pp. 1381-1391

2019

  1. Splice donor site sgRNAs enhance CRISPR/ Cas9-mediated knockout efficiency

    PLoS ONE, Vol. 14, Núm. 5

2018

  1. Targeted genome editing in acute lymphoblastic leukemia: A review

    BMC Biotechnology, Vol. 18, Núm. 1

2017

  1. The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia

    Oncotarget, Vol. 8, Núm. 16, pp. 26027-26040

2016

  1. C14ORF39/SIX6OS1 is a constituent of the synaptonemal complex and is essential for mouse fertility

    Nature Communications, Vol. 7

2014

  1. Mutant cohesin in premature ovarian failure

    New England Journal of Medicine, Vol. 370, Núm. 10, pp. 943-949

  2. STAG3 is a strong candidate gene for male infertility

    Human Molecular Genetics, Vol. 23, Núm. 13, pp. 3421-3431